SunTrust analyst Tobey Sommer raised his price target on eHealth to $200 and kept his Buy rating as part of a broader research note on government services beneficiaries, calling the stock the "most profound growth opportunity we have ever covered." The analyst sees the company growing its market share in Medicare Advantage from 1% to 6%-7% over the next 3 years while growing at a 50% annual rate vs. consensus expectations of 27%. Sommer cites eHealth's platforms offering the most plans on the most carriers while also noting its unique online plan recommendation engine.

Still expects 2024 GAAP net income ($40M)-($20M) and adjusted EBITDA ($5M)-$20M.